Form 4: Organon SVP Controller Reports Stock Transactions

Organon & Co.'s SVP and Corporate Controller, Lynette Holzbaur, reported the acquisition of common stock from restricted stock unit vesting and a subsequent sale for tax withholding.

Summary

• Lynette Holzbaur, SVP and Corporate Controller of Organon & Co., reported transactions involving the company's common stock.
• On November 5, 2025, 3,037 shares of common stock were acquired at a price of $0, resulting from the vesting of restricted stock units.
• Concurrently, 866 shares of common stock were disposed of at a price of $6.52, likely to cover tax obligations related to the vesting.
• Following these transactions, the reporting person beneficially owns 12,948.427 shares of Organon common stock.
• The restricted stock units vest in three equal installments, with the first vesting on November 5, 2025, and the final vesting on November 5, 2027.
• After the reported transactions, 6,076 restricted stock units remain beneficially owned.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to equity compensation vesting and tax withholding, which is neutral in sentiment.

Positives

• Vesting of restricted stock units indicates continued compensation and retention of a key executive.
• The acquisition of 3,037 shares of common stock at $0 reflects the successful conversion of equity awards.

Negatives

• The disposition of 866 shares, while for tax purposes, reduces the direct shareholding of the executive.

Future Outlook

NA

Industry Context

This is a routine insider transaction filing, common across all industries for executives receiving equity compensation. It does not provide specific industry context.

Related Party Transactions

• The reported transactions are related party transactions as they involve an executive of Organon & Co. acquiring and disposing of company stock.

Stakeholder Impact

• Shareholders: Provides transparency into executive equity compensation and ownership changes.
• Employees: Reflects the company's executive compensation structure, which may influence employee perception of equity programs.

Next Steps

• Future vesting of the remaining 6,076 restricted stock units will occur in installments, with the final vesting on November 5, 2027.

Key Dates

Keywords

Organon & Co., OGN, SEC Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU Vesting, Lynette Holzbaur, Corporate Controller, Equity Compensation